Andrzej Januszewski

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

Chemical modification of proteins during peroxidation of phospholipids.

Lipid-derived modifications of plasma proteins in experimental and human diabetes.

Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus.

Increased coated-platelet levels in chronic haemodialysis patients.

Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors.

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.

Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects.

Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells.

Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia.

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.

The longitudinal association between inflammation and incident depressive symptoms in men: the effects of hs-CRP are independent of abdominal obesity and metabolic disturbances.